1. Home
  2. TRVI vs NSP Comparison

TRVI vs NSP Comparison

Compare TRVI & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$12.79

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$21.36

Market Cap

834.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVI
NSP
Founded
2011
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
834.9M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
TRVI
NSP
Price
$12.79
$21.36
Analyst Decision
Strong Buy
Hold
Analyst Count
12
3
Target Price
$20.38
$47.67
AVG Volume (30 Days)
1.2M
1.2M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
11.23%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,812,000,000.00
Revenue This Year
N/A
$4.27
Revenue Next Year
N/A
$5.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.51
52 Week Low
$4.24
$20.42
52 Week High
$14.39
$95.98

Technical Indicators

Market Signals
Indicator
TRVI
NSP
Relative Strength Index (RSI) 67.21 23.44
Support Level $9.80 N/A
Resistance Level $14.39 $48.32
Average True Range (ATR) 0.65 1.63
MACD 0.24 -0.12
Stochastic Oscillator 95.28 9.44

Price Performance

Historical Comparison
TRVI
NSP

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: